🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/1991 | 20,08 | 20,34 | 20,00 | 20,02 | -0,30% | 1,68% | 2.754.773 |
| 22/08/1991 | 20,12 | 20,18 | 20,02 | 20,08 | -0,10% | 0,79% | 3.204.994 |
| 21/08/1991 | 19,76 | 20,12 | 19,72 | 20,10 | +2,95% | 2,01% | 6.094.330 |
| 20/08/1991 | 19,68 | 19,70 | 19,40 | 19,52 | +0,00% | 1,52% | 5.625.874 |
| 19/08/1991 | 18,61 | 19,60 | 18,61 | 19,52 | -1,70% | 5,34% | 9.809.909 |
| 16/08/1991 | 20,00 | 20,12 | 19,68 | 19,86 | -0,70% | 2,19% | 5.923.925 |
| 15/08/1991 | 20,12 | 20,24 | 19,96 | 20,00 | -0,49% | 1,38% | 2.800.046 |
| 14/08/1991 | 20,30 | 20,30 | 20,06 | 20,10 | -0,49% | 1,18% | 2.524.632 |
| 13/08/1991 | 20,22 | 20,42 | 20,12 | 20,20 | +0,00% | 1,47% | 3.061.627 |
| 12/08/1991 | 20,10 | 20,24 | 20,04 | 20,20 | +0,40% | 0,99% | 1.404.110 |
| 09/08/1991 | 20,24 | 20,28 | 20,12 | 20,12 | -0,78% | 0,79% | 1.916.582 |
| 08/08/1991 | 20,32 | 20,46 | 20,24 | 20,28 | -0,68% | 1,08% | 2.532.806 |
| 07/08/1991 | 20,36 | 20,63 | 20,32 | 20,42 | +0,20% | 1,56% | 3.197.448 |
| 06/08/1991 | 20,14 | 20,44 | 19,96 | 20,38 | +1,38% | 2,37% | 4.023.062 |
| 05/08/1991 | 20,26 | 20,26 | 19,98 | 20,10 | -0,98% | 1,37% | 2.298.893 |
| 02/08/1991 | 20,44 | 20,48 | 20,26 | 20,30 | -0,49% | 1,07% | 2.725.219 |
| 01/08/1991 | 20,46 | 20,50 | 20,32 | 20,40 | -0,39% | 0,87% | 2.757.917 |
| 31/07/1991 | 20,26 | 20,50 | 20,24 | 20,48 | +1,08% | 1,28% | 3.238.949 |
| 30/07/1991 | 19,92 | 20,28 | 19,84 | 20,26 | +2,10% | 2,20% | 4.596.528 |
| 29/07/1991 | 19,60 | 19,86 | 19,52 | 19,84 | +1,22% | 1,72% | 3.287.366 |
| 26/07/1991 | 19,58 | 19,74 | 19,58 | 19,60 | +0,10% | 0,81% | 3.152.803 |
| 25/07/1991 | 19,32 | 19,58 | 19,24 | 19,58 | +1,55% | 1,75% | 2.914.488 |
| 24/07/1991 | 19,14 | 19,28 | 19,04 | 19,28 | +0,83% | 1,25% | 2.090.131 |
| 23/07/1991 | 19,24 | 19,34 | 19,08 | 19,12 | -0,41% | 1,34% | 2.599.459 |
| 22/07/1991 | 19,22 | 19,22 | 19,08 | 19,20 | -0,31% | 0,72% | 3.257.184 |
| 19/07/1991 | 19,32 | 19,40 | 19,18 | 19,26 | -0,31% | 1,13% | 5.088.878 |
| 18/07/1991 | 19,20 | 19,34 | 19,08 | 19,32 | +0,62% | 1,35% | 3.625.032 |
| 17/07/1991 | 19,20 | 19,38 | 19,20 | 19,20 | -0,21% | 0,93% | 1.882.627 |
| 16/07/1991 | 19,34 | 19,44 | 19,16 | 19,24 | -0,51% | 1,44% | 2.498.222 |
| 15/07/1991 | 19,08 | 19,48 | 19,04 | 19,34 | +1,46% | 2,29% | 4.133.731 |